Accuray (NASDAQ:ARAY) reported quarterly earnings results on February 04, 2026 that fell short of analyst expectations.
The Healthcare company reported earnings per share of $-0.11, missing the consensus estimate of $-0.07 by $0.04 per share. Revenue came in at $102.2M, beating the estimate of $100.9M.
Accuray's stock moved following the earnings release. The stock currently trades at $0.65 with a market capitalization of $125.8M.


